发明名称 |
Deuterated n-ethyl-n-phenyl-1,2-dihydro-4-hydroxy-5-chloro-1-methyl-2-oxoquinoline-3-carboxamide, salts and uses thereof |
摘要 |
<p>The disclosure provides deuterated N-ethyl-N-phenyl-1,2-dihydro-4-hydroxy-5-chloro-1-methyl-2-oxoquinoline-3-carboxamide (deuterated laquinimod), its salts, pharmaceutical compositions comprising them and uses. Disclosed uses include treatment of autoimmune diseases such as Multiple Sclerosis, Systemic Lupus Erythematosus, lupus nephritis, lupus arthritis, Crohn’s Disease or Rheumatoid arthritis.</p> |
申请公布号 |
NZ606587(A) |
申请公布日期 |
2015.03.27 |
申请号 |
NZ20110606587 |
申请日期 |
2011.07.08 |
申请人 |
TEVA PHARMACEUTICAL INDUSTRIES LTD. |
发明人 |
PIRYATINSKY VICTOR;LAXER AVITAL |
分类号 |
A01N43/42;A61K31/047;A61K31/4704;C07B59/00;C07D215/22;C07D215/54;C07D215/56 |
主分类号 |
A01N43/42 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|